Cargando…

SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva

Surface-Enhanced Raman Scattering (SERS) can obtain the spectroscopic response of specific analytes. In controlled conditions, it is a powerful quantitative technique. However, often the sample and its SERS spectrum are complex. Pharmaceutical compounds in human biofluids with strong interfering sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Tommasini, Matteo, Lucotti, Andrea, Stefani, Luca, Trusso, Sebastiano, Ossi, Paolo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254353/
https://www.ncbi.nlm.nih.gov/pubmed/37298786
http://dx.doi.org/10.3390/molecules28114309
_version_ 1785056622278606848
author Tommasini, Matteo
Lucotti, Andrea
Stefani, Luca
Trusso, Sebastiano
Ossi, Paolo M.
author_facet Tommasini, Matteo
Lucotti, Andrea
Stefani, Luca
Trusso, Sebastiano
Ossi, Paolo M.
author_sort Tommasini, Matteo
collection PubMed
description Surface-Enhanced Raman Scattering (SERS) can obtain the spectroscopic response of specific analytes. In controlled conditions, it is a powerful quantitative technique. However, often the sample and its SERS spectrum are complex. Pharmaceutical compounds in human biofluids with strong interfering signals from proteins and other biomolecules are a typical example. Among the techniques for drug dosage, SERS was reported to detect low drug concentrations, with analytical capability comparable to that of the assessed High-Performance Liquid Chromatography. Here, for the first time, we report the use of SERS for Therapeutic Drug Monitoring of the Anti-Epileptic Drug Perampanel (PER) in human saliva. We used inert substrates decorated with gold NPs deposited via Pulsed Laser Deposition as SERS sensors. We show that it is possible to detect PER in saliva via SERS after an optimized treatment of the saliva sample. Using a phase separation process, it is possible to extract all the diluted PER in saliva from the saliva phase to a chloroform phase. This allows us to detect PER in the saliva at initial concentrations of the order of 10(−7) M, thus approaching those of clinical interest.
format Online
Article
Text
id pubmed-10254353
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102543532023-06-10 SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva Tommasini, Matteo Lucotti, Andrea Stefani, Luca Trusso, Sebastiano Ossi, Paolo M. Molecules Article Surface-Enhanced Raman Scattering (SERS) can obtain the spectroscopic response of specific analytes. In controlled conditions, it is a powerful quantitative technique. However, often the sample and its SERS spectrum are complex. Pharmaceutical compounds in human biofluids with strong interfering signals from proteins and other biomolecules are a typical example. Among the techniques for drug dosage, SERS was reported to detect low drug concentrations, with analytical capability comparable to that of the assessed High-Performance Liquid Chromatography. Here, for the first time, we report the use of SERS for Therapeutic Drug Monitoring of the Anti-Epileptic Drug Perampanel (PER) in human saliva. We used inert substrates decorated with gold NPs deposited via Pulsed Laser Deposition as SERS sensors. We show that it is possible to detect PER in saliva via SERS after an optimized treatment of the saliva sample. Using a phase separation process, it is possible to extract all the diluted PER in saliva from the saliva phase to a chloroform phase. This allows us to detect PER in the saliva at initial concentrations of the order of 10(−7) M, thus approaching those of clinical interest. MDPI 2023-05-24 /pmc/articles/PMC10254353/ /pubmed/37298786 http://dx.doi.org/10.3390/molecules28114309 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tommasini, Matteo
Lucotti, Andrea
Stefani, Luca
Trusso, Sebastiano
Ossi, Paolo M.
SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva
title SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva
title_full SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva
title_fullStr SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva
title_full_unstemmed SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva
title_short SERS Detection of the Anti-Epileptic Drug Perampanel in Human Saliva
title_sort sers detection of the anti-epileptic drug perampanel in human saliva
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254353/
https://www.ncbi.nlm.nih.gov/pubmed/37298786
http://dx.doi.org/10.3390/molecules28114309
work_keys_str_mv AT tommasinimatteo sersdetectionoftheantiepilepticdrugperampanelinhumansaliva
AT lucottiandrea sersdetectionoftheantiepilepticdrugperampanelinhumansaliva
AT stefaniluca sersdetectionoftheantiepilepticdrugperampanelinhumansaliva
AT trussosebastiano sersdetectionoftheantiepilepticdrugperampanelinhumansaliva
AT ossipaolom sersdetectionoftheantiepilepticdrugperampanelinhumansaliva